AR113780A1 - Síntesis de análogos de aminoglicósidos antibacterianos - Google Patents
Síntesis de análogos de aminoglicósidos antibacterianosInfo
- Publication number
- AR113780A1 AR113780A1 ARP180103039A ARP180103039A AR113780A1 AR 113780 A1 AR113780 A1 AR 113780A1 AR P180103039 A ARP180103039 A AR P180103039A AR P180103039 A ARP180103039 A AR P180103039A AR 113780 A1 AR113780 A1 AR 113780A1
- Authority
- AR
- Argentina
- Prior art keywords
- analogues
- synthesis
- antibacterial aminoglycoside
- diastereomers
- enantiomers
- Prior art date
Links
- 229940126575 aminoglycoside Drugs 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- MKIHFLQNZUDOQW-UHFFFAOYSA-N (4-nitrophenyl)methyl benzotriazole-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)N1C2=CC=CC=C2N=N1 MKIHFLQNZUDOQW-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
- C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762574544P | 2017-10-19 | 2017-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR113780A1 true AR113780A1 (es) | 2020-06-10 |
Family
ID=64110232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180103039A AR113780A1 (es) | 2017-10-19 | 2018-10-18 | Síntesis de análogos de aminoglicósidos antibacterianos |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11453658B2 (https=) |
| EP (1) | EP3697797A1 (https=) |
| JP (3) | JP7235741B2 (https=) |
| CN (1) | CN111655709B (https=) |
| AR (1) | AR113780A1 (https=) |
| AU (2) | AU2023219819B2 (https=) |
| CA (1) | CA3079508A1 (https=) |
| EA (1) | EA202090980A1 (https=) |
| MX (1) | MX2020003701A (https=) |
| TW (1) | TWI801438B (https=) |
| WO (1) | WO2019079613A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019079613A1 (en) * | 2017-10-19 | 2019-04-25 | Achaogen, Inc. | SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGUES |
| CN110878108B (zh) * | 2019-06-17 | 2022-11-11 | 山东安信制药有限公司 | 一种普拉佐米星的合成方法 |
| CN110885350A (zh) * | 2019-08-28 | 2020-03-17 | 山东安信制药有限公司 | 一种普拉佐米星的制备方法 |
| CN110642907B (zh) * | 2019-10-12 | 2020-11-06 | 上海博璞诺科技发展有限公司 | 普拉唑米星或其盐的合成方法 |
| CN111116688B (zh) * | 2020-01-07 | 2021-07-27 | 杭州华东医药集团新药研究院有限公司 | 普拉佐米星的制备方法 |
| CN111205341A (zh) * | 2020-02-17 | 2020-05-29 | 山东安信制药有限公司 | 一种普拉佐米星关键中间体的制备方法 |
| CN112079882B (zh) * | 2020-10-10 | 2021-10-08 | 山东安信制药有限公司 | 一种Plazomicin的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4388233A (en) * | 1981-05-15 | 1983-06-14 | The Regents Of The University Of California | Synthetic substrates for enzyme analysis |
| MX2009003909A (es) | 2006-10-12 | 2009-05-25 | Ptc Therapeutics Inc | Métodos para dosificar un compuesto 1,2,4, - oxadiazol oralmente activo para el tratamiento de supresión de la mutación finalizadora. |
| US8614233B2 (en) * | 2007-05-29 | 2013-12-24 | Universite De Montreal | Cinnamoyl inhibitors of transglutaminase |
| LT2217610T (lt) | 2007-11-21 | 2017-02-27 | Achaogen, Inc. | Antibakteriniai aminoglikozidų analogai |
| EP2103602A1 (en) * | 2008-03-17 | 2009-09-23 | AEterna Zentaris GmbH | Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| CA2761674C (en) * | 2009-05-14 | 2016-11-29 | Achaogen, Inc. | Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds |
| CA2761756A1 (en) * | 2009-05-14 | 2010-11-18 | Achaogen, Inc. | Treatment of urinary tract infections with antibacterial aminoglycoside compounds |
| WO2010147836A1 (en) | 2009-06-17 | 2010-12-23 | Achaogen, Inc. | Combination therapies using antibacterial aminoglycoside compounds |
| WO2011143497A1 (en) * | 2010-05-12 | 2011-11-17 | Rempex Pharmaceuticals, Inc. | Aminoglycoside derivatives |
| US9238670B2 (en) * | 2013-03-15 | 2016-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Aminoglycoside antibiotics with reduced ototoxicity |
| WO2019079613A1 (en) * | 2017-10-19 | 2019-04-25 | Achaogen, Inc. | SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGUES |
-
2018
- 2018-10-18 WO PCT/US2018/056536 patent/WO2019079613A1/en not_active Ceased
- 2018-10-18 CA CA3079508A patent/CA3079508A1/en active Pending
- 2018-10-18 EA EA202090980A patent/EA202090980A1/ru unknown
- 2018-10-18 CN CN201880081473.5A patent/CN111655709B/zh active Active
- 2018-10-18 JP JP2020522054A patent/JP7235741B2/ja active Active
- 2018-10-18 AR ARP180103039A patent/AR113780A1/es unknown
- 2018-10-18 EP EP18797440.7A patent/EP3697797A1/en active Pending
- 2018-10-18 TW TW107136676A patent/TWI801438B/zh active
- 2018-10-18 MX MX2020003701A patent/MX2020003701A/es unknown
-
2020
- 2020-04-16 US US16/850,771 patent/US11453658B2/en active Active
-
2022
- 2022-08-04 US US17/881,462 patent/US12122769B2/en active Active
-
2023
- 2023-02-24 JP JP2023027439A patent/JP2023054316A/ja not_active Withdrawn
- 2023-08-22 AU AU2023219819A patent/AU2023219819B2/en active Active
-
2024
- 2024-09-20 US US18/892,191 patent/US20250122177A1/en active Pending
-
2025
- 2025-01-31 JP JP2025015211A patent/JP2025062009A/ja active Pending
- 2025-09-05 AU AU2025226793A patent/AU2025226793A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN111655709A (zh) | 2020-09-11 |
| US12122769B2 (en) | 2024-10-22 |
| US20250122177A1 (en) | 2025-04-17 |
| US20230074115A1 (en) | 2023-03-09 |
| AU2018353156A1 (en) | 2020-05-07 |
| EP3697797A1 (en) | 2020-08-26 |
| JP2025062009A (ja) | 2025-04-11 |
| MX2020003701A (es) | 2020-07-22 |
| EA202090980A1 (ru) | 2020-10-07 |
| CN111655709B (zh) | 2024-01-02 |
| JP2021500354A (ja) | 2021-01-07 |
| WO2019079613A1 (en) | 2019-04-25 |
| CA3079508A1 (en) | 2019-04-25 |
| US20200317652A1 (en) | 2020-10-08 |
| RU2020116171A (ru) | 2021-11-19 |
| AU2023219819A1 (en) | 2023-09-07 |
| BR112020007740A2 (pt) | 2020-10-13 |
| AU2025226793A1 (en) | 2025-09-25 |
| JP2023054316A (ja) | 2023-04-13 |
| TWI801438B (zh) | 2023-05-11 |
| JP7235741B2 (ja) | 2023-03-08 |
| US11453658B2 (en) | 2022-09-27 |
| TW201922233A (zh) | 2019-06-16 |
| RU2020116171A3 (https=) | 2022-03-03 |
| AU2023219819B2 (en) | 2025-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR113780A1 (es) | Síntesis de análogos de aminoglicósidos antibacterianos | |
| AR119761A2 (es) | Benzamidas sustituidas con 1,3-tiazol-2-ilo | |
| CL2020003219A1 (es) | Compuestos | |
| AR107519A1 (es) | Compuestos de piperidina sustituido y su uso | |
| AR119672A1 (es) | Inhibidor de 15-pgdh | |
| CL2017000705A1 (es) | Nuevos compuestos | |
| MX380394B (es) | Compuesto novedoso de bifenilo o una sal del mismo. | |
| PE20170206A1 (es) | Inhibidores espirociclicos sustituidos de la autotaxina | |
| AR095523A1 (es) | Derivados piridin-4-ilo | |
| AR101995A1 (es) | COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6 | |
| MX392829B (es) | Analogos sinteticos de las ecteinascidinas y su uso como agentes antitumorales | |
| PE20181924A1 (es) | Inhibidores de la arginasa y sus aplicaciones terapeuticas | |
| AR106141A1 (es) | Métodos e intermediarios para la preparación de derivados de ácidos biliares | |
| AR098274A1 (es) | Inhibidor de grelina o-acil transferasa | |
| CY1121626T1 (el) | Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου | |
| AR089814A1 (es) | Compuestos que modulan la actividad de los proteasomas | |
| AR095097A1 (es) | Compuestos de fenoxietoxi | |
| AR105821A1 (es) | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T | |
| EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
| AR107132A1 (es) | Cocristal, método de producción del mismo, y medicamento que contiene dicho cocristal | |
| MX2021006692A (es) | Proceso mejorado para preparar ozanimod. | |
| EP3756664A4 (en) | UROLITHIN CONTAINING OSTEOCLAST DIFFERENTIATION INHIBITOR | |
| AR102019A1 (es) | (r)-3-((3s,4s)-3-fluoro-4-(4-hidroxifenil)piperidin-1-il)-1-(4-metilbencil)pirrolidin-2-ona y sus profármacos para el tratamiento de trastornos psiquiátricos | |
| CU24560B1 (es) | N-(4,4-difluorociclohexil)-2-(3-metil-1h-pirazol-1-il)-6-morfolinopirimidin-4-amina útil como modulador de canales de potasio | |
| AR112695A1 (es) | Inhibidores de cdpk1, composiciones y métodos relacionados con los mismos |